维普期刊资源整合服务平台（V6.5）

609篇 您的检索式：作者名="Remuzzi G"

选中清除导出查看参考文献查看引证文献引用追踪共31页首页上一页第1页下一页末页 /31 跳转

	题名	作者	年代	出处	被引量
1	Pathophysiology of progressive nephropathies 显示文摘	Remuzzi G Bertain T	1998	N Engl J Med1998，339，20：	1
2	Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition显示文摘	Remuzzi G Ruggenenti P Perico N	2002	Ann Intern Med2002，136，8：	1
3	Platelet dysfunction inrenal failure 显示文摘	Boccardo P Remuzzi G Galbusera M	2004	Semin Thromb Hemost2004，30，5：	1
4	Albuminuria atherapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy 显示文摘	De Zeeuw D Remuzzi G Parving HH	2004	Circulation2004，110，8：	1
5	Transplant renal artery stenosis显示文摘	Bruno S Remuzzi G Ruggenenti P	2004	J Am Soc Nephrol2004，15，13：	1
6	Rituximab for idio- pathic membranous nephropathy 显示文摘	Remuzzi G Chiurchiu C Abbate M	2002	Lancet2002，360，9337：	1
7	Understanding the nature of renal disease progression显示文摘	Remuzzi G Ruggenenti P Benigni A	1997	Kidney Int1997，51，1：	1
8	Automatic generation of glomerular capillary topological organization 显示文摘	Antiga L Ene-Lordache B Remuzzi G	2001	Microvasc Res2001，62，3：	1
9	Understanding the nature of renal disease progression显示文摘	Remuzzi G Ruggenenti P Benigni A	1997	Kidney Int1997，51，1：	1
10	The role of renln-angiotensin-aldosterone system in the progression of chronic kidney disease 显示文摘	Remuzzi G Perico N Macia M	2005	Kidney Int Suppl2005，，99：	1
11	How renal cytokines and growth factor contribute to renal disease progression显示文摘	Remuzzi G	2001	AmJ Kidney Dis2001，37，2：	1
12	Pathophysiology of progressive nephropathies 显示文摘	Remuzzi G Bertani T	1998	N Engl J Med1998，39，20：	1
13	Albuminuria is a target for renoprotective therapy independent from blood pres- sure in patients with type 2 diabetic nephropathy: post hoc a- nalysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) tria显示文摘	Eijkelkamp WB Zhang Z Remuzzi G	2007	J Am Soc Nephrol2007，18，5：	1
14	Progression, remission, regression of chronic renal diseases 显示文摘	Ruggenenti R Schieppati A Remuzzi G	2001	Lancet2001，357，9268：	1
15	Early Experience with Dual Kidney Transplantation in Adults Using Expanded Donor Criteria显示文摘	Remuzzi G Grinyo J Ruggenenti P	1999	J Am Soc Nephrol1999，10，：	1
16	VonWillebrand factor cleaving protease(ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome显示文摘	Remuzzi G Galbusera M Noris M	2002	Blood2002，10，3：	1
17	Cellular responses to pro- tein overload: key event in renal disease progression 显示文摘	ZOJA C BENIGNI A REMUZZI G	2004	Curr Opin Nephrol Hypertens2004，13，1：	1
18	Albuminuria,a thera-peutic target for cardiovascular protection in type 2 diabeticpatients with nephropathy 显示文摘	de Zeeuw D Remuzzi G Parving HH	2004	Circulation2004，110，8：	1
19	Undersranding the nature of renal disease progression 显示文摘	Remuzzi G Ruggenenti P Benigni A	1997	Kidney Int1997，51，：	1
20	Albuminuriais a target for renoprotective therapy independent from bloodpressure in patients with type 2 diabetic nephropathy: post hocanalysis from the Reduction of Endpoints in NIDDM with theAngiotensin II Antagonist Losartan (RENAAL) trial显示文摘	EUKELKAMP WB ZHANG Z REMUZZI G	2007	J Am SocNephrol2007，18，5：	1

返回顶部每页显示：

共31页首页上一页第1页下一页末页 /31 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示